BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34826617)

  • 1. How to adapt an intestinal microbiota transplantation programme to reduce the risk of invasive multidrug-resistant infection.
    Ghani R; Mullish BH; Davies FJ; Marchesi JR
    Clin Microbiol Infect; 2022 Apr; 28(4):502-512. PubMed ID: 34826617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized With Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell Transplantation.
    Innes AJ; Mullish BH; Ghani R; Szydlo RM; Apperley JF; Olavarria E; Palanicawandar R; Kanfer EJ; Milojkovic D; McDonald JAK; Brannigan ET; Thursz MR; Williams HRT; Davies FJ; Marchesi JR; Pavlů J
    Front Cell Infect Microbiol; 2021; 11():684659. PubMed ID: 34513724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of fecal microbiota transplantation for decolonization of intestinal multidrug-resistant microorganism carriage: beyond
    Yoon YK; Suh JW; Kang EJ; Kim JY
    Ann Med; 2019; 51(7-8):379-389. PubMed ID: 31468999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Amoxicillin-Clavulanate followed by Autologous Fecal Microbiota Transplantation on Fecal Microbiome Structure and Metabolic Potential.
    Bulow C; Langdon A; Hink T; Wallace M; Reske KA; Patel S; Sun X; Seiler S; Jones S; Kwon JH; Burnham CA; Dantas G; Dubberke ER
    mSphere; 2018 Nov; 3(6):. PubMed ID: 30463925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal microbiota transplantation for eradicating carriage of multidrug-resistant organisms: a systematic review.
    Saha S; Tariq R; Tosh PK; Pardi DS; Khanna S
    Clin Microbiol Infect; 2019 Aug; 25(8):958-963. PubMed ID: 30986562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease Prevention Not Decolonization: A Model for Fecal Microbiota Transplantation in Patients Colonized With Multidrug-resistant Organisms.
    Ghani R; Mullish BH; McDonald JAK; Ghazy A; Williams HRT; Brannigan ET; Mookerjee S; Satta G; Gilchrist M; Duncan N; Corbett R; Innes AJ; Pavlů J; Thursz MR; Davies F; Marchesi JR
    Clin Infect Dis; 2021 Apr; 72(8):1444-1447. PubMed ID: 32681643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement.
    Woodworth MH; Conrad RE; Haldopoulos M; Pouch SM; Babiker A; Mehta AK; Sitchenko KL; Wang CH; Strudwick A; Ingersoll JM; Philippe C; Lohsen S; Kocaman K; Lindner BG; Hatt JK; Jones RM; Miller C; Neish AS; Friedman-Moraco R; Karadkhele G; Liu KH; Jones DP; Mehta CC; Ziegler TR; Weiss DS; Larsen CP; Konstantinidis KT; Kraft CS
    Sci Transl Med; 2023 Nov; 15(720):eabo2750. PubMed ID: 37910603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.
    Su F; Luo Y; Yu J; Shi J; Zhao Y; Yan M; Huang H; Tan Y
    Eur J Med Res; 2021 Apr; 26(1):37. PubMed ID: 33910622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Use of Microbiome Restoration Therapeutics to Eliminate Intestinal Colonization With Multidrug-Resistant Organisms.
    Gopalsamy SN; Woodworth MH; Wang T; Carpentieri CT; Mehta N; Friedman-Moraco RJ; Mehta AK; Larsen CP; Kraft CS
    Am J Med Sci; 2018 Nov; 356(5):433-440. PubMed ID: 30384952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiota-associated risk factors for asymptomatic gut colonisation with multi-drug-resistant organisms in a Dutch nursing home.
    Ducarmon QR; Terveer EM; Nooij S; Bloem MN; Vendrik KEW; Caljouw MAA; Sanders IMJG; van Dorp SM; Wong MC; Zwittink RD; Kuijper EJ
    Genome Med; 2021 Apr; 13(1):54. PubMed ID: 33827686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic Surveillance Reveals Diversity of Multidrug-Resistant Organism Colonization and Infection: A Prospective Cohort Study in Liver Transplant Recipients.
    Macesic N; Gomez-Simmonds A; Sullivan SB; Giddins MJ; Ferguson SA; Korakavi G; Leeds D; Park S; Shim K; Sowash MG; Hofbauer M; Finkel R; Hu Y; West J; Toussaint NC; Greendyke WG; Miko BA; Pereira MR; Whittier S; Verna EC; Uhlemann AC
    Clin Infect Dis; 2018 Aug; 67(6):905-912. PubMed ID: 29718144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of donor multidrug-resistant organisms on solid organ transplant recipient outcomes.
    Anesi JA; Blumberg EA; Han JH; Lee DH; Clauss H; Hasz R; Molnar E; Alimenti D; Motzer AR; West S; Bilker WB; Tolomeo P; Lautenbach E;
    Transpl Infect Dis; 2022 Feb; 24(1):e13783. PubMed ID: 34968006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal Microbiota Transplantation for multidrug-resistant organism: Efficacy and Response prediction.
    Seong H; Lee SK; Cheon JH; Yong DE; Koh H; Kang YK; Jeong WY; Lee WJ; Sohn Y; Cho Y; Hyun JH; Baek YJ; Kim MH; Kim JH; Ahn JY; Ku NS; Jeong SJ; Yeom JS; Cho MS; Lee JH; Kim BY; Choi JY
    J Infect; 2020 Nov; 81(5):719-725. PubMed ID: 32920061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faecal microbiota replacement to eradicate antimicrobial resistant bacteria in the intestinal tract - a systematic review.
    Bilsen MP; Lambregts MMC; van Prehn J; Kuijper EJ
    Curr Opin Gastroenterol; 2022 Jan; 38(1):15-25. PubMed ID: 34636363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug-Resistant Gram-Negative Bacteria Decolonization in Immunocompromised Patients: A Focus on Fecal Microbiota Transplantation.
    Alagna L; Palomba E; Mangioni D; Bozzi G; Lombardi A; Ungaro R; Castelli V; Prati D; Vecchi M; Muscatello A; Bandera A; Gori A
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32764526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wisconsin microbiome study, a cross-sectional investigation of dietary fibre, microbiome composition and antibiotic-resistant organisms: rationale and methods.
    Eggers S; Malecki KM; Peppard P; Mares J; Shirley D; Shukla SK; Poulsen K; Gangnon R; Duster M; Kates A; Suen G; Sethi AK; Safdar N
    BMJ Open; 2018 Mar; 8(3):e019450. PubMed ID: 29588324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD study.
    Langdon A; Schwartz DJ; Bulow C; Sun X; Hink T; Reske KA; Jones C; Burnham CD; Dubberke ER; Dantas G;
    Genome Med; 2021 Feb; 13(1):28. PubMed ID: 33593430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal microbiota transplantation and successful resolution of multidrug-resistant-organism colonization.
    Crum-Cianflone NF; Sullivan E; Ballon-Landa G
    J Clin Microbiol; 2015 Jun; 53(6):1986-9. PubMed ID: 25878340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periodic screening of donor faeces with a quarantine period to prevent transmission of multidrug-resistant organisms during faecal microbiota transplantation: a retrospective cohort study.
    Vendrik KEW; Terveer EM; Kuijper EJ; Nooij S; Boeije-Koppenol E; Sanders IMJG; van Lingen E; Verspaget HW; Berssenbrugge EKL; Keller JJ; van Prehn J;
    Lancet Infect Dis; 2021 May; 21(5):711-721. PubMed ID: 33275940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.